Results 21 to 30 of about 18,540 (231)

Sarcopenia and Sarcopenic Obesity [PDF]

open access: yesEndocrinology and Metabolism, 2013
The aging process is associated with progressive loss of muscle mass and strength, as well as decline in physical functioning. Although consensus diagnosis has not been reached, sarcopenia is increasingly defined by both loss of muscle mass and loss of muscle function or strength.
openaire   +4 more sources

The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity [PDF]

open access: yes, 2019
Background & aims: The metabolic and functional characteristics related to sarcopenic obesity have not been thoroughly explored in the earlier stages of the aging process.
Catalano, Carlo   +7 more
core   +1 more source

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle [PDF]

open access: yes, 2017
The estimates of global incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) are worrisome, due to the parallel burden of obesity and its metabolic complications. Indeed, excess adiposity and insulin resistance represent two of the major
Chiesa, Claudio   +4 more
core   +2 more sources

Decreased intracellular water is associated with sarcopenic obesity in chronic haemodialysis patients

open access: yesBMC Geriatrics, 2023
Objective To explore the association between intracellular water (ICW) and sarcopenic obesity in patients undergoing chronic haemodialysis (HD).
Maolu Tian   +5 more
doaj   +1 more source

A pilot study of temsirolimus and body composition. [PDF]

open access: yes, 2013
PurposeBody weight and composition play a role in cancer etiology, prognosis, and treatment response. Therefore, we analyzed the weight, body composition changes, and outcome in patients treated with temsirolimus, an mTor inhibitor that has weight loss ...
Janku, Filip   +6 more
core   +2 more sources

Fatty liver index associates with relative sarcopenia and GH/ IGF- 1 status in obese subjects [PDF]

open access: yes, 2016
Recently the association between hepatic steatosis and sarcopenia has been described. GH/IGF-1 axis has been postulated to play a role in linking fatty liver and low muscle mass.
Donini, Lorenzo Maria   +5 more
core   +2 more sources

Research Progress of Sarcopenic Obesity in Cancer [PDF]

open access: yesZhongguo quanke yixue
As the number of obese and elderly population increases worldwide, sarcopenic obesity is becoming associated with a higher risk of adverse events and outcomes in multiple clinical situations, including cancer.
PENG Lei, ZHU Kexiang
doaj   +1 more source

Malnutrition, poor food intake, and adverse healthcare outcomes in non-critically ill obese acute care hospital patients [PDF]

open access: yes, 2018
Obesity, defined as a BMI\ua0≥\ua030\ua0kg/m, has demonstrated protective associations with mortality in some diseases. However, recent evidence demonstrates that poor nutritional status in critically ill obese patients confounds this relationship.
Agarwal, Ekta   +7 more
core   +2 more sources

Prevalence and risk factors of sarcopenia among adults living in nursing homes [PDF]

open access: yes, 2015
Objectives: Sarcopenia is a progressive loss of skeletal muscle and muscle function, with significant healthand disability consequences for older adults.
Beller, Elaine M.   +4 more
core   +1 more source

Understanding factors associated with sarcopenic obesity in older African women from a low-income setting: a cross-sectional analysis

open access: yesBMC Geriatrics, 2021
Background High rates of food insecurity, obesity and obesity-related comorbidities in ageing South African (SA) women may amplify the risk of developing sarcopenic obesity.
Amy E. Mendham   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy